ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RGLS Regulus Therapeutics Inc

1.42
0.00 (0.00%)
Pre Market
Last Updated: 08:00:15
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 1.40
Ask Price 1.50
News -
Day High

Low
0.76

52 Week Range

High
1.8499

Day Low
Company Name Stock Ticker Symbol Market Type
Regulus Therapeutics Inc RGLS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 1.42 08:00:15
Open Price Low Price High Price Close Price Prev Close
1.42
Trades Volume Avg Volume 52 Week Range
0 0 - 0.76 - 1.8499
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 1.42 USD

Regulus Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
28.72M 20.22M - 0 -28.32M -1.40 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Regulus Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No RGLS Message Board. Create One! See More Posts on RGLS Message Board See More Message Board Posts

Historical RGLS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.501.591.411.5248,186-0.08-5.33%
1 Month1.261.741.16091.4949,1620.1612.70%
3 Months1.381.741.081.3735,2980.042.90%
6 Months1.651.84991.081.4335,051-0.23-13.94%
1 Year1.321.84990.761.3339,6210.107.58%
3 Years1.272.43990.15760.90394771,062,6050.1511.81%
5 Years1.282.43990.15760.9336446983,5050.1410.94%

Regulus Therapeutics Description

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes.

Your Recent History

Delayed Upgrade Clock